We have also previously reported that knockdown of CB1R signaling effectively attenuates the hyperglycemia-induced upregulation of c-Jun, TGF-β1, IL-6, and TNF-α in vitro and in vivo [32]. The gene discussed is TGFB1; the disease is Hyperglycemia.